Skip to content
Latest News
Scirocco Energy Shares Rallied 6.45% on Discounted Ruvuma Seismic Contract Award

Shares of Scirocco Energy PLC (LON: SCIR) rallied 6.45% after revealing that the operator for its Ruvuma joint venture project had awarded the contract for seismic mapping for the Chikumbi-1 well at a significant discount. Investors cheered the fa

Simon Mugo
Microsaic Systems (MSYS) Shares Rally After Signing Deal with Jiangsu Henzhihe Technologies

Microsaic Systems (MSYS) shares are gaining on Friday after it announced the signing of an agreement with Jiangsu Henzhihe Technologies (HZH). Microsaic, a developer of p

Sam Boughedda
Quadrise Fuels (QFI) Shares Rallied 21.8% After Successfully Testing Greenfield Samples

Shares of Quadrise Fuels International Plc (LON: QFI) rallied 21.8% after conducting a series of tests for Tomco Energy’s Greenfield project in Utah and presenting positive results to the client. According to Tomco Energy, the tests carried out by

Simon Mugo
Scottish Mortgage (SMT) Shares Just Broke Out to New All-Time Highs. What’s Next?

Shares of Scottish Mortgage Investment Trust PLC (LON: SMT) just broke to new all-time highs reaching a high of 1458p earlier today. What’s next for the fund? The investment fund’s bet on growth stocks continues to pay off as the cyclical rotation

Simon Mugo
Four Seasons Edu (FEDU) Stock Price Soared 69.1% on a $15M Share Buyback Program

Four Seasons Edu (Cayman) Inc ADR (NYSE: FEDU) stock price soared 69.1% after its board authorised a $15 million share repurchase program. The company, which provides after-school education services, is based in Shanghai, China. The share repurcha

Simon Mugo
Eargo Stock Plunged 61.6% As the DOJ Investigates It Filing of Customer Insurance Claims

Eargo Inc (NASDAQ: EAR) stock plunged 61.6% after revealing that it was being investigated by the U.S. Department of Justice regarding insurance claims filed on behalf of its customers. The hearing aids company was quickly downgraded by analysts f

Simon Mugo
Transcode Therapeutics (RNAZ) Stock Price Gapped Up 62.8% on Breast Cancer Drug Results

Shares of Transcode Therapeutics Inc (NASDAQ: RNAZ) gapped 62.8% higher after publishing positive preclinical data supporting the therapeutic potential of its lead drug candidate, TTX-MC138, which targets metastatic cancers. The imaging study publ

Simon Mugo
MEDIROM Healthcare Technologies Stock Rallies On Acquisition of ZACC Kabushiki Kaisha

MEDIROM Healthcare Technologies (Nasdaq: MRM) shares are rallying premarket on news that it has entered into a deal to acquire ZACC Kabushiki Kaisha. ZACC is a Japanese h

Sam Boughedda
Amplitude Healthcare (AMHC) Stock Surges As Shareholders Approve Jasper Therapeutics Merger

Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC), a special purpose acquisition company, has seen its shares surge premarket after announcing that its stockholders voted to approve the business combinatio

Sam Boughedda
Rockhopper Exploration (RKH) Shares Plunge Following Harbour Energy Decision

Rockhopper Exploration (LON: RKH) shares plunged on Thursday after Harbour Energy announced it would not proceed with the Sea Lion project.  The Sea Lion project, with in

Sam Boughedda
Union Jack Oil (UJO) Shares Fall After Raising £3m Via Placing

Union Jack Oil (LON: UJO) shares are down Thursday after announcing it has raised £3 million from a placing of 13.6 million new ordinary shares. The UK-focused onshore hy

Sam Boughedda
XLMedia Shares Fall After Reporting a H1 Loss

Shares of digital performance publisher XLMedia (LON: XLM) fell Thursday after the company reported a pretax loss for the six months ended 30 June 2021. The AIM-quoted fi

Sam Boughedda
Workhorse Group (WKHS) Stock Slide After Suspending C-1000 Deliveries

Workhorse Group (NASDAQ: WKHS) shares plunged Wednesday after the company decided to suspend deliveries of C-1000 vehicles and recall 41 cars it had already delivered. Wo

Sam Boughedda
Cassava Sciences (SAVA) Stock Rally On Positive Simufilam Data

Shares of Cassava Sciences (NASDAQ: SAVA) are rallying premarket after the company announced top-line clinical data from a pre-planned interim analysis of an ongoing open-label study with its drug candidate simufila

Sam Boughedda
Predictive Oncology (POAI) Stock Rallied 22.68% Despite Not Releasing Any Significant News

Predictive Oncology Inc (NASDAQ: POAI) stock rallied 22.68% during the premarket session despite not making any substantial moves today. The lack of news drivers behind today’s rally point to a push by retail investors to accumulate the precision

Simon Mugo
Aethlon Medical (AEMD) Stock Rallied 41.8% As Retail Investors Push Prices Higher

Aethlon Medical, Inc. (NASDAQ: AEMD) stock rallied 44.73% during premarket trading despite not making any announcements today, in what some are calling a short squeeze. However, the company’s shares are not widely shorted; hence, today’s rally cou

Simon Mugo
Glencore Shares Are Up 38.6% This Year but Face Resistance at 340p. Can They Break Out?

Shares of Glencore PLC (LON: GLEN) are up 38.6% this year, driven by the booming commodity prices that saw its pre-tax profits surge 79% to a record $8.7 billion in the first half of 2021 compared to the $4.8 billion generated in H1 2020. The comp

Simon Mugo
Marin Software (MRIN) Stock Rallied 84.9% on New Google Search Revenue Contract

Marin Software Inc (NASDAQ: MRIN) rallied 84.89% premarket after signing a new revenue-sharing agreement with Google that comes into effect on October 1, 2021, after the termination of the current contract on September

Simon Mugo
Spire Global Shares Gain Premarket After Announcing Myriota Partnership

Space-based data, analytics, and space services company Spire Global (NYSE: SPIR) shares are up slightly premarket on Wednesday following the announcement of a partnership with Myriota.

Sam Boughedda
Corvus Pharmaceuticals (CRVS) Stock Climbs Premarket Following Mupadolimab Update

 Corvus Pharmaceuticals (NASDAQ: CRVS) shares are gaining premarket Wednesday after the company provided an update on its development programs in oncology and infectious disease for mupadolimab.

Sam Boughedda